Célebre Pro Medic

13/03/2024

CELL THERAPIES FOR AUTISM SPECTRUM DISORDER BASED ON NEW PATHOPHYSIOLOGY: A REVIEW

Autism Spectrum Disorder (ASD), a neurodevelopmental disorder with increased global prevalence, lacks effective therapy. Rapid evidence links ASD to neuroinflammation, microglia, and glucose metabolism. Ten cell therapy studies for ASD report positive outcomes. Neurophysiological impairments include communication, cognition, and motor skills. Emerging focus on immune pathology and glucose metabolism suggests new avenues for ASD treatment.

Research on ASD and neuroinflammation, microglia, and glucose metabolism has surged. Cell therapies, especially MSCs, emerge as promising ASD treatments. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069005/

Reach out to us for further insights!
Facebook: https://www.facebook.com/CelebrePro.Malaysia/
Contact us : 019 - 266 6065

[By Celebre Pro Medic Sdn Bhd]

08/03/2024

BENGALURU (Jan 31): Alps Global Holding Bhd agreed on Wednesday to go public in the US through a merger with a blank-cheque company, in a deal that values the biotechnology company at US$1.6 billion.

07/03/2024

''1st CLINICAL & PRACTICAL SKILLS WORKSHOP 2024''
CELESOME(+) ON PAIN RELIEF

Event Details:-
📅 Date: 26/03/2024 (Tuesday)
⌚ Time: 12:30PM – 6:00PM
📍 Venue: Alps Medical Centre, Level 2,
Menara See Hoy Chan, KL.

Agenda Highlights:-
👉 In-depth insights on Celesome(+)
🤝 Networking with fellow doctors
👐 Hands-on practical sessions
🌐 Stay updated on pain relief advancements

Exciting Updates:-
We're thrilled to announce that attendees will receive exclusive access to the latest research and a chance to explore cutting-edge pain relief solutions.

Unlock the power of your expertise in our workshop! Join us and let's learn together.

07/03/2024

"THE POTENTIAL USE OF MESENCHYMAL STEM CELLS AND THEIR DERIVED EXOSOMES FOR ORTHOPEDIC DISEASES TREATMENT"

1- Osteoporosis is one of the most common age-related skeletal disorders that, in many cases, can lead to bone fractures, and its prevalence is higher in women than men.

2- Exosomes of MSCs contain GLUT3 protein and mRNA. This protein is one of the most important osteoblast differentiation markers and maturation, which increases significantly in hFOB1.19 cells treated with exosomes derived from MSCs.

3- MSC exosomes contain mitochondrial proteins and improve NPCs' mitochondrial function by transferring these proteins to them. Studies show that these exosomes can merge with mitochondria mambrane after entering the NPCs. Besides, MSCs exosomes contain anti-oxidant proteins such as Trap 1, Gpx 4, and Prdx-1, preventing apoptosis by transporting them to cells containing oxidative stress.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224994/

[Celebre Pro Medic Sdn Bhd]

28/07/2023

THE ROLE OF MESENCHYMAL STEM CELLS IN THE TREATMENT OF TYPE 1 DIABETES

Umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) are abundant in the umbilical cord's subcortical endothelium and Wharton's jelly. Studies show their potential in treating Type 1 diabetes (T1D) by differentiating into insulin-producing cells and aiding islet cell preservation. UC-MSCs can also address complications like neuropathy and retinopathy. Their non-invasive collection process and lack of ethical concerns make them a promising therapeutic option. Further research is needed to optimize doses and understand their full potential in T1D treatment.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414788/

Discover the limitless potential of STEMCELL and MSC - reach out to us for further insights!
Facebook: https://www.facebook.com/CelebrePro.Malaysia/
Contact us : 019 - 266 6065

[By Celebre Pro Medic Sdn Bhd 20230728]

05/06/2023

[ Célebre ] Dirgahayu
MERAFAK SEMBAH DAN SETINGGI TINGGI UCAPAN TAHNIAH

KEBAWAH DULI YANG MAHA MULIA SERI PADUKA BAGINDA YANG DI-PERTUAN AGONG AL-SULTAN ABDULLAH RI'AYATUDDIN AL-MUSTAFA BILLAH SHAH IBNI ALMARHUM SULTAN HAJI AHMAD SHAH AL-MUSTA'IN BILLAH

sempena
Sambutan Ulang Tahun Hari Keputeraan Rasmi Kebawah Duli Yang Maha Mulia Tuanku

pada
5 JUN 2023 bersamaan 16 ZULKAEDAH 1444H

31/05/2023

[ Celebre ] Symposium on
THERAPEUTIC APPLICATIONS OF STEM CELLS:
CURRENT AND FUTURE PROSPECTS

28th May 2023

19/05/2023

[MyGenome X National Cancer Society Malaysia]

Unlocking the Secrets of Cancer: Join us for an engaging virtual lecture on the fundamentals of genomics in oncology with Prof. Manickam Ravichandran.
Don't miss out on this enlightening event! Download the Docquity app now and use this link below to join us!:

https://docquity.app.link/umhkbwzVUzb

National Cancer Society Malaysia Docquity

03/05/2023

[ Célebre ] 📣Attention Doctors!📣
Join us for a symposium on the Therapeutic Application of Stem Cells: Current and Future Prospects, organized by Celebre Pro Medic Sdn Bhd.

🗓️Date: 28th May 2023 (Sunday)
🏫Venue: Hibiscus Room, DoubleTree by Hilton KL, Level 10
🕰️Time: 09:00am to 06:00pm
👔Dress code: Smart Casual

🎉This symposium is accredited with 08 CPD points. Register online via the link given below by 13th May 2023 to secure your spot.

https://m5.gs/RE1HZU

Early Bird (1st 10 pax): RM10 per pax
Regular Fee: RM150 per pax

For further inquiries, please contact Ms Chloe at:
☎️ 019-266 6065 or 011-1077 5577

Don't miss out on this opportunity to expand your knowledge in the field of stem cells. See you there!👋🏻

Introduction to ALPS; cGMP stem cell & Genomic Facilities by Prof Ravi, Stem Cell and Diabetes: Preclinical Proof of Concept Studies by Prof Ding Ke Xiang and Dr THAM.....

21/03/2023

"Revolutionizing Autoimmune Disorder Treatment: The Promise of Umbilical Cord Mesenchymal Stem Cells"

Autoimmune disorders are caused by an overactive immune system that attacks the body's own tissues and organs, leading to chronic inflammation and tissue damage. Traditional treatments for autoimmune disorders, such as corticosteroids and immunosuppressants, can have limited efficacy and cause adverse side effects. However, recent research has shown that UCMSCs have immunomodulatory properties and the ability to suppress immune responses, making them a promising therapy for autoimmune disorders.

UCMSCs are a type of stem cell that can be obtained from the umbilical cord tissue after birth. They have the unique ability to differentiate into a variety of cell types, including bone, cartilage, and fat cells, and have been shown to have immunomodulatory effects on various immune cells. UCMSCs can regulate the function of T cells, B cells, natural killer cells, and dendritic cells, which are all involved in the development and progression of autoimmune disorders.

Studies have shown that UCMSCs can reduce inflammation and promote tissue regeneration in animal models of autoimmune disorders, such as multiple sclerosis and rheumatoid arthritis. UCMSC therapy has also been tested in small clinical trials for autoimmune disorders, with promising results. However, more research is needed to determine the safety and efficacy of UCMSC therapy for autoimmune disorders in larger clinical trials.

In conclusion, UCMSCs have shown potential as a novel therapy for autoimmune disorders due to their immunomodulatory properties and ability to suppress immune responses. UCMSC therapy may offer a safer and more effective alternative to traditional treatments for autoimmune disorders, but more research is needed to establish its safety and efficacy in humans.

Contact us now to know more about MSC!
[Celebre Pro Medic Sdn Bhd]

17/03/2023

"The use of umbilical cord mesenchymal stem cells in bone repair"

Umbilical cord MSCs have emerged as a promising candidate for bone repair and regeneration due to their unique characteristics. These stem cells have the potential to differentiate into bone-forming cells and promote bone regeneration, making them a valuable tool in the field of orthopedics.

One of the benefits of umbilical cord MSCs is that they can be obtained easily and non-invasively, without causing harm to the donor. This means that they can be readily available for use in bone repair procedures.

Moreover, umbilical cord MSCs have shown remarkable potential for promoting bone regeneration in preclinical studies. In animal models of bone defects and injuries, these stem cells have been shown to enhance bone formation and improve bone density, leading to better functional outcomes.

Overall, umbilical cord MSCs hold great promise for the future of bone repair and regeneration. As research continues in this field, it is likely that these stem cells will become an increasingly important tool in the orthopedic surgeon's arsenal.

Contact us now to know more about MSC!
[Celebre Pro Medic Sdn Bhd]

16/03/2023

"Revolutionizing Regenerative Medicine: Unlocking the Power of Umbilical Cord Stem Cells"

Discover the potential of umbilical cord mesenchymal stem cells (UCMSCs) in regenerative medicine. These powerful stem cells offer unique characteristics such as the ability to differentiate into various cell types, low immunogenicity, and a high proliferation rate. With the potential to treat bone, cartilage, and muscle damage, Parkinson's disease, liver failure, type 1 diabetes, and immune-related disorders, UCMSCs offer hope for patients in need.

Unlike other stem cell sources, UCMSCs are easily isolated and expanded in culture from the umbilical cord, which is a discarded post-birth tissue, with no ethical concerns. Challenges remain, but the standardization of isolation and culture methods, optimization of differentiation protocols, and development of safe and effective delivery methods are underway.

With continued research and development, UCMSCs have the potential to transform regenerative medicine and improve the lives of those suffering from debilitating diseases and injuries. Join us in unlocking the power of umbilical cord stem cells and revolutionizing regenerative medicine.

Contact us now to know more about MSC!
[Celebre Pro Medic Sdn Bhd]